Journal of Laboratory Physicians
Home About us Ahead of print Current issue Back issues Subscribe Instructions Contact Login 
Wide layoutNarrow layoutPrint this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 


 
   Table of Contents     
ORIGINAL ARTICLE
Year : 2018  |  Volume : 10  |  Issue : 1  |  Page : 17-20  

Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country Pakistan


1 Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan
2 Department of Anatomy, Liaquat National Medical College, Karachi, Pakistan
3 Department of Pathology and Laboratory Medicine, The Aga Khan University Hospital, Karachi, Pakistan

Date of Submission11-Jan-2017
Date of Acceptance30-Jun-2017
Date of Web Publication03-Jan-2018

Correspondence Address:
Dr. Sadia Sultan
Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi
Pakistan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JLP.JLP_9_17

Rights and Permissions
   Abstract 


BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin's lymphoma (NHL). Hence, we reviewed the demographical profile along with bone marrow infiltration pattern in patients with NHL presented at Liaquat National Hospital and Medical College.
MATERIALS AND METHODS: In this descriptive study, adult patients with NHL were enrolled from January 2011 to December 2015.
RESULTS: One hundred and Eighty-four histopathologically confirmed cases of NHL were identified. There were 139 males and 45 females, with a male-to-female ratio of 3:1. The mean age was 48.5 ± 16.0 years with the median age of 50 years. B-symptoms were present in 80.4% of patients. Lymph node enlargement was present in 71.1% of the cases. One hundred and sixty-eight patients had B-cell lymphoma (91.3%) and 16 patients had T-cell lymphoma (8.6%). Overall 158 (85.8%) patients had aggressive lymphoma. The frequency of bone marrow infiltration in our NHL patients was found to be 31.5%. Pattern of infiltrate was diffuse (14.6%) predominantly followed by interstitial (6.5%) and paratrabecular (5.4%) types of infiltration. The least common was nodular infiltrate accounted in 9 (4.8%) patients.
CONCLUSIONS: B-cell lymphoma is more frequent than T-cell lymphoma. Younger age, aggressive lymphoma, and predominance of B-symptoms are more frequently seen. Diffuse bone marrow infiltration is more common in our set up probably because of a relatively late presentation in our patients.

Keywords: Non-Hodgkin's lymphoma, Pakistan, WHO subtypes


How to cite this article:
Sultan S, Baloch N, Ahmed ZA, Irfan SM, Parveen S. Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country Pakistan. J Lab Physicians 2018;10:17-20

How to cite this URL:
Sultan S, Baloch N, Ahmed ZA, Irfan SM, Parveen S. Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country Pakistan. J Lab Physicians [serial online] 2018 [cited 2018 Oct 19];10:17-20. Available from: http://www.jlponline.org/text.asp?2018/10/1/17/222173




   Introduction Top


Non-Hodgkin lymphoma (NHL) is a broad group of lymphoma comprising divergent tumors with variable clinical behaviors. NHL tends to be a disease of older age in North America and Europe.[1] It is characterized by neoplastic transformation of lymphoid lineage with the high potential for spread to various tissues throughout the body, especially bone marrow, liver, and spleen.[2],[3]

Bone marrow biopsy is an essential component of staging workup in NHL and those patients presenting with bone marrow infiltration and/or other tissues are in Stage IV disease have shown poor prognosis and response to therapy.[4] It has been regularly reported that patients in developing countries often present at a relatively advanced stage in comparison with patients from the Western site.[5],[6],[7]

Bone trephine biopsy not only permits an assessment of infiltration but also the pattern and extent of infiltrate can be determined, which carries both diagnostic and prognostic significance.[8] At times, trephine biopsy may demonstrate lymphoma even when no abnormal cells have been identified in peripheral blood and bone marrow smears. Lymphomatous infiltrations by NHL are observed in various distinct patterns.

This report describes the demographical data, clinical features, and laboratory findings in NHL patients. Second, we also determined the frequency and pattern of bone marrow infiltration by NHL at the time of diagnosis.


   Materials and Methods Top


This descriptive study was conducted over a period of 5 years from January 2011 to December 2015 at Hematology Department of Liaquat National Hospital. All NHL cases were diagnosed by morphology on hematoxylin and eosin sections and immunohistochemical (IHC) profile according to the WHO classification of lymphoid neoplasms. IHC stains using antibodies against CD 20, CD 3, CD 10, CD 5, CD 23, BCL2, cyclin D1, and CD 79a were done in each case.[9] Additional CD markers were applied if deemed necessary. Adult patients diagnosed as NHL who were ≥15 years of age were included in this analysis.

A total of 184 participants with newly diagnosed untreated NHL were included in this study. Complete blood counts were determined by automated analyzer (Cell Dyn counter). Bone marrow aspirate and trephine specimens were taken from posterior iliac spine by the standard technique after written consent. The bone marrow slides were reviewed by two hematopathologists, and the following data were collected: clinical diagnosis, lymphoma subtype, and pattern of involvement.

Statistical analysis

Data were collected and analyzed using the Statistical Package for the Social Sciences version 22.0 (SPSS Inc, Chicago, IL, USA). The results were expressed as mean (± standard deviation) for quantitative variables and are presented as frequency and percentages for qualitative variables.


   Results Top


Demographic characteristics

Out of 184 patients, 139 were male (75.5%) and 45 were female (24.4%) with male-to-female ratio of 3:1. Age ranged between 16 and 74 years with the mean age was 48.5 ± 16.0 years and the median age of 50 years. Majority of patients (60.8%) were under 50 years of age.

Clinical findings

B-symptoms were present in 80.4% of patients, out of which low-grade fever was most common seen in 120 (65.2%), night sweating in 59.2%, while 84 (45.6%) patients had a history of weight loss. Lymph node enlargement was present in 71.1% cases. The splenomegaly and hepatomegaly were noted in 33 (17.9%) and 22 (11.9%) patients, respectively.

Subtypes of non-Hodgkin's lymphoma

168 patients had B-cell lymphoma (91.3%) and 16 had T-cell (8.6%) lymphoma. Overall 158 (85.8%) patients had aggressive lymphoma and remaining 26 (14.1%) had indolent disease. Histopathologically, diffuse large B-cell lymphoma (DLBCL) constituted major subtype in 125 (67.9%) patients, followed by follicular lymphoma in 14 (7.6%) patients and marginal lymphoma in 3.8% patients; 3.2% patients had mantle cell lymphoma, 2.7% patients of anaplastic large cell, and 2.1% patients each for Burkitt's lymphoma and T-cell-rich lymphoma. The least encounter was small lymphocytic lymphoma in 1.6% patients as shown in [Figure 1].
Figure 1: Spectrum of NHL

Click here to view


In T-cell neoplasm, peripheral T-cell lymphoma and adult T-cell lymphoma are the main variants accountable in 4.3% and 3.2% patients, respectively. Merely, two patients (1.0%) were presented with mycosis fungoid.

Laboratory features

Mean hemoglobin was 10.8 ± 2.7 g/dl with the mean corpuscular volume of 82.2 ± 8.8 fl. The mean total leukocyte count was 9.0 ± 6.5 × 109/L, mean absolute neutrophil count was 4.3 ± 3.2 × 109/L, and the mean platelet count was 201.9 ± 129.3 × 109/L. Anemia (Hb <10 g/dl) was noted in 21 (11.4%) patients as shown in [Table 1].
Table 1: Descriptive statistics and laboratory parameters

Click here to view


The frequency of bone marrow infiltration in our NHL patients was found to be 31.5% (n = 58). Overall, the pattern of infiltrate was diffuse in 27 (14.6%) patients, followed by interstitial in 12 (6.5%) patients and paratrabecular infiltrate in 10 (5.4%) patients. The least encountered type was nodular in 9 (4.8%) of patients as shown in [Figure 2]. Diffuse infiltrate is frequently seen in DLBCL patients while paratrabecular variant was seen in indolent lymphomas [Figure 3].
Figure 2: Pattern of bone trephine infiltrate in non-Hodgkin's lymphoma

Click here to view
Figure 3: Paratrabecular infiltrate in follicular lymphoma

Click here to view



   Discussion Top


Geographically, Pakistan is located in the “lymphoma belt,” which geological boundaries are broadening from Southwestern Asia to Middle East to Northern Africa.[7] Today lymphoma is a major health problem all over the world. Its incidence is increasing largely attributed to NHL. As Hodgkin's lymphoma accounts for only ~10% of all lymphomas and the remaining 90% of cases are of NHL type globally.[10]

Regional data regarding lymphoma are limited; hence, an insight is needed to identify the disease spectrum and burden locally. The risk of NHL amplifies with the age. Mostly patients are diagnosed in their sixth or seventh decade of life. NHL is a disease of older age in Europe countries.[1] However, the median age of disease onset is ~50 years in our series. Studies from India and Southern Punjab also reveal the average age for NHL to be between 40 and 45 years, which is in concurrence to our findings.[11],[12] Age discordance with Western studies may be explicated by relatively longer life expectancy and more elder population in the West.

Among the NHL, B-cell NHL is much more common than T-cell variant worldwide.[13] DLBCL is the most common malignant B-cell lymphoma all over the world, and we also determined the same in our series.[2],[14]

Staging of the NHL is foremost important for the therapeutic decisions in the management of these patients. Lymphomatous infiltration by NHL indicates advanced Stage IV disease, is usually recognized in distinct patterns, and includes interstitial pattern, in which lymphoid cells are loosely dispersed amidst hematopoietic tissue; diffuse (packed marrow) pattern, in which lymphoid cells are densely packed within the marrow spaces; lymphoid nodular pattern, in which multiple, partly confluent nodular aggregates of lymphoid cells are recognized; and paratrabecular pattern, in which the lymphoid infiltrate is adjacent to bony trabecula.

Literature searched from within the country has shown three published studies regarding marrow infiltrates by NHL. In these studies, the predominant pattern of lymphoma tissue infiltrates is diffuse variant in 46.3% and 66% cases, followed by focal aggregates and paratrabecular infiltrates.[15],[16],[17] In the present study, the most common pattern of bone marrow infiltration was that of diffuse type, followed by interstitial and paratrabecular pattern of invasion.

A previous study reported from Turkey revealed relatively lower prevalence of lymphomatous infiltration (18.7%) when compared with our results.[18] In contrast to our findings, the Western studies have shown patterns of bone marrow infiltration varying from mainly focal, paratrabecular, or interstitial to diffuse intermittently.[19] We found high rate of diffuse infiltration in our series, and this perhaps reflects that most of our patients present late when disease has already been advanced to Stage IV. The comparative pattern of bone trephine infiltrate with others studies is shown in [Table 2].
Table 2: Comparison of bone trephine infiltration pattern with other studies

Click here to view



   Conclusions Top


Finally, NHL occurs at a younger median age in Pakistan. B-cell lymphoma is more frequent than T-cell lymphoma with DLBCL being the most common NHL. Aggressive lymphoma and predominance of B-symptoms are more frequently seen. Diffuse bone marrow infiltration is more common in our set up probably because of a relatively late presentation in our patients.

Acknowledgment

The authors sincerely thank all patients. We are also thankful to Mr. Zain Mahmood for data analysis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Chakrabarti S, Sarkar S, Goswami BK, Mondal S, Roy A, Das S. Hodgkin's and Non-Hodgkin's lymphomas in an Indian Rural medical institution: Comparative clinicopathologic analysis. Asian Pac J Cancer Prev 2010;11:1605-8.  Back to cited text no. 1
[PUBMED]    
2.
Hazarika M, Iqbal A, Krishnatreya M, Sharma JD, Bhuyan C, Saikia BJ, et al. Adult non-Hodgkin's lymphoma patients: Experience from a tertiary care cancer centre in North East India. Asian Pac J Cancer Prev 2015;16:2879-81.  Back to cited text no. 2
[PUBMED]    
3.
Dehghani M, Haddadi S, Vojdani R. Signs, symptoms and complications of non-Hodgkin's lymphoma according to grade and stage in South Iran. Asian Pac J Cancer Prev 2015;16:3551-7.  Back to cited text no. 3
[PUBMED]    
4.
Knauf WU, Gückel F, Döhner H, Semmler W, Trümper L, Ho AD. Detection of bone marrow infiltration by non-Hodgkin's lymphoma – comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging. Klin Wochenschr 1991;69:345-50.  Back to cited text no. 4
    
5.
Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, et al. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pac J Cancer Prev 2008;9:229-32.  Back to cited text no. 5
[PUBMED]    
6.
Gad-el-Mawla N, Hamza MR, Abdel-Hadi S, el-Tannir O, Hussein MH, el-Haddad A, et al. Prolonged disease-free survival in pediatric non-Hodgkin's lymphoma using ifosfamide-containing combination chemotherapy. Hematol Oncol 1991;9:281-6.  Back to cited text no. 6
[PUBMED]    
7.
Bukhari U, Jamal S, Lateef F. Non-Hodgkin lymphoma-A study. Pak Oral Dent J 2015;35:412-5.  Back to cited text no. 7
    
8.
Durosinmi MA, Mabayoje VO, Akinola NO. A review of histology of bone marrow trephine in malignant lymphomas. Niger J Med 2003;12:198-201.  Back to cited text no. 8
[PUBMED]    
9.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.  Back to cited text no. 9
    
10.
Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848-57.  Back to cited text no. 10
[PUBMED]    
11.
Obafunwa JO, Akinsete I. Malignant lymphomas in Jos, Nigeria: A ten-year study. Cent Afr J Med 1992;38:17-25.  Back to cited text no. 11
[PUBMED]    
12.
Abrar A, Sadaqat AG. Non-Hodgkin's lymphoma in South Punjab. Retrospective analysis of 148 patients. Pak J Med Res 1989;28:223-31.  Back to cited text no. 12
    
13.
Kim JM, Ko YH, Lee, SS, Huh J, Kang CS, Kim CW, et al. WHO classification of malignant lymphomas in Korea: Report of the third Nationwide study. Korean J Pathol 2011;45:254-60.  Back to cited text no. 13
    
14.
Lee SJ, Suh CW, Lee SI, Kim WS, Lee WS, Kim HJ, et al. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: Nationwide Korean study. Korean J Intern Med 2014;29:352-60.  Back to cited text no. 14
[PUBMED]    
15.
Malik S, Ahmad S, Saleem M. Bone marrow involvement in non-Hodgkin's lymphoma. A study of 41 untreated cases. Pak Armed Forces Med J 1992;42:90-2.  Back to cited text no. 15
    
16.
Hassan K, Ikram N, Bukhari KP, Shah SH. The pattern of bone marrow infiltration in non-Hodgkin's lymphomas. J Pak Med Assoc 1995;45:173-6.  Back to cited text no. 16
[PUBMED]    
17.
Jamila, Hassan K. Pattern of bone marrow infiltration in non-Hodgkin's lymphomas. J Rawal Med Coll 2008:12:66-71.  Back to cited text no. 17
    
18.
Isikdogan A, Ayyildiz O, Buyukcelik A, Arslan A, Tiftik N, Buyukbayram H, et al. Non-Hodgkin's lymphoma in southeast Turkey: Clinicopathologic features of 490 cases. Ann Hematol 2004;83:265-9.  Back to cited text no. 18
[PUBMED]    
19.
Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: Frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 2005;29:1549-57.  Back to cited text no. 19
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
 
  Search
 
  
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusions
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed603    
    Printed15    
    Emailed0    
    PDF Downloaded75    
    Comments [Add]    

Recommend this journal